Annual Report 2006–07

學術發展 Academic Development 35 The State Key Laboratory in Oncology in South China at CUHK officially opened on 16 November 2006. This national-level scientific research centre will focus on those highly prevalent cancers in Asia. Being the only state key laboratory in Hong Kong for cancers, its strategic location has promoted the readiness for research output to be translated into clinical solutions that will benefit the patients. The national standing granted to the laboratory represents the State’s recognition of the University’s unremitting efforts and academic excellence in medical research, while at the same time serving as an important platform for extending its scientific achievements to benefit the wider Chinese community. A delegation from the Shenzhen Health Bureau visited the Faculty of Medicine on 29 September 2006 for further collaboration with CUHK following the signing of a memorandum of understanding earlier in June in the same year. Various departments from the Faculty of Medicine held meetings with the Shenzhen delegation and came up with solid proposals in the areas of continuing medical education and training of family doctors and nurses. • • CUHK successfully obtained approval from the State Food and Drug Administration (SFDA) of China on 1 August 2006 to carry out clinical trials for registration purposes in China. The approval covered digestive diseases, oncology, endocrinology, ophthalmology, cardiology, paediatric (hematology), paediatric (respiratory), paediatric (immunology), paediatric (infectious diseases) and bioequivalence trials. The SFDA accreditation has significant implications on health care development in the Asia-Pacific region, especially in China. Hong Kong will play a strategic role in fostering global collaboration between pharmaceutical and biotechnology companies to enhance development of drugs and medical devices. A forum was held on 1 November 2006 to explore how the academia and the industry can capitalize on the potential opportunities triggered by SFDA. In recognition of a generous donation of HK$25 million from Dr. Stanley Ho, G.B.S., to support research into infectious diseases, CUHK has named the Centre for Emerging Infectious Diseases after him. The naming ceremony of the Stanley Ho Centre for Emerging Infectious Diseases took place at the Prince of Wales Hospital on 16 November 2006. The centre is in a position to scale new heights in its work against the outbreak and spread of infectious diseases in Hong Kong, Macau and the neighbouring region. • • 華南腫瘤學國家重點實驗室（香港中文大學）開幕 Opening of the State Key Laboratory in Oncology in South China at CUHK 何鴻燊防治傳染病研究中心命名典禮 The naming ceremony of the Stanley Ho Centre for Emerging Infectious Diseases